Machine Learning: A New Approach for Dose Individualization
Clinical Pharmacology & Therapeutics · 2024
DOI: 10.1002/cpt.3049 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Pharmacology & Therapeutics, 2024. Verfasst von Qiu-Yue Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Institute of Clinical Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education),NMPA Key Laboratory f…. Hauptthemen laut MEDLINE: Machine Learning, Precision Medicine. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: the National Key Research and Development Program of China, National Natural Science Foundation of China, the Distinguished Young and Middle-aged Scholar of Shandong University.
Abstract (Originalsprache)
The application of machine learning (ML) has shown promising results in precision medicine due to its exceptional performance in dealing with complex multidimensional data. However, using ML for individualized dosing of medicines is still in its early stage, meriting further exploration. A systematic review of study designs and modeling details of using ML for individualized dosing of different drugs was performed. We have summarized the status of the study populations, predictive targets, and data sources for ML modeling, the selection of ML algorithms and features, and the evaluation and validation of their predictive performance. We also used the Prediction model Risk of Bias Assessment Tool (PROBAST) to assess the risk of bias of included studies. Currently, ML can be used for both a priori and a posteriori dose selection and optimization, and it can also assist the implementation of therapeutic drug monitoring. However, studies are mainly focused on drugs with narrow therapeutic windows, predominantly immunosuppressants ( N = 23, 35.9%) and anti‐infectives ( N = 21, 32.8%), and there is currently only very limited attention for special populations, such as children ( N = 22, 34.4%). Most studies showed poor methodological quality and a high risk of bias. The lack of external validation and clinical utility evaluation currently limits the further clinical implementation of ML for dose individualization. We therefore have proposed several ways to improve the clinical relevance of the studies and facilitate the translation of ML models into clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Institute of Clinical Pharmacology, Key Laboratory of Chemical Biology (Ministry of Education),NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, School of Phar…
- Division of Clinical Pharmacology, Children's National Hospital, Washington, DC, USA.
- Departments of Pediatrics, Pharmacology & Physiology, Genomics & Precision Medicine, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
- Department of Pediatric Pharmacology and Pharmacometrics, University of Basel Children's Hospital, Basel, Switzerland.
- NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, Qilu Hospital of Shandong University, Shandong University, Jinan, China.
ORCID-Profile: Wei Zhao
Förderung
- the National Key Research and Development Program of China
- National Natural Science Foundation of China
- the Distinguished Young and Middle-aged Scholar of Shandong University
- Innovation and Development Joint Fund of Natural Science Foundation of Shandong Province
- Natural Science Foundation of Shandong Province
- Taishan Scholar Program of Shandong Province
Zitieren
APA
Li, Q. Y., Tang, B. H., Wu, Y. E., Yao, B. F., Zhang, W., Zheng, Y., Zhou, Y., van den Anker, J., Hao, G. X., & Zhao, W. (2024). Machine Learning: A New Approach for Dose Individualization. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3049
Vancouver
Li QY, Tang BH, Wu YE, Yao BF, Zhang W, Zheng Y, et al. Machine Learning: A New Approach for Dose Individualization. Clinical Pharmacology & Therapeutics. 2024. doi:10.1002/cpt.3049
BibTeX
@article{Li2024,
author = {Li, Qiu-Yue and Tang, Bo-Hao and Wu, Yue-E and Yao, Bu-Fan and Zhang, Wei and Zheng, Yi and Zhou, Yue and van den Anker, John and Hao, Guo-Xiang and Zhao, Wei},
title = {Machine Learning: A New Approach for Dose Individualization},
journal = {Clinical Pharmacology & Therapeutics},
year = {2024},
doi = {10.1002/cpt.3049}
}
EUVIMED